elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q37662513-197347DE-FF8D-4F7E-879E-BBAA8AF0EEC3
Q37662513-197347DE-FF8D-4F7E-879E-BBAA8AF0EEC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37662513-197347DE-FF8D-4F7E-879E-BBAA8AF0EEC3
Clinical development of hepatitis C virus host-targeting agents.
P2860
Q37662513-197347DE-FF8D-4F7E-879E-BBAA8AF0EEC3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37662513-197347DE-FF8D-4F7E-879E-BBAA8AF0EEC3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0cbb5de63f7dc8b617565e9b17a8738f21bc0232
P2860
miR-122--a key factor and therapeutic target in liver disease.